Log in to save to my catalogue

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9500647

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

About this item

Full title

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

Publisher

Switzerland: MDPI AG

Journal title

Journal of clinical medicine, 2022-09, Vol.11 (18), p.5369

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Discovering novel risk and prognostic factors for COVID-19 may help not only in reducing severity and mortality but also in creating targeted therapies considering patients’ individual features. Liver fibrosis is considered a complication in Non-alcoholic Fatty Liver Disease (NAFLD), it is a feature of steatohepatitis (NASH), and it has already bee...

Alternative Titles

Full title

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9500647

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9500647

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm11185369

How to access this item